Design Therapeutics, Inc.
DSGN
$15.62
-$0.17-1.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 222.82M | 219.85M | 205.97M | 216.28M | 229.67M |
| Total Receivables | 1.82M | 1.68M | 1.38M | 1.35M | 1.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.40M | 2.26M | 1.68M | 2.17M | 2.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 227.05M | 223.78M | 209.03M | 219.79M | 233.64M |
|
|
|||||
| Total Current Assets | 227.05M | 223.78M | 209.03M | 219.79M | 233.64M |
| Net Property, Plant & Equipment | 3.39M | 2.42M | 2.74M | 3.09M | 3.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 427.00K |
| Total Assets | 230.44M | 226.20M | 211.77M | 222.89M | 237.48M |
|
|
|||||
| Total Accounts Payable | 2.28M | 2.31M | 1.91M | 1.01M | 3.18M |
| Total Accrued Expenses | 7.38M | 9.85M | 8.39M | 6.89M | 4.24M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 536.00K | 890.00K | 866.00K | 844.00K | 821.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.19M | 13.06M | 11.17M | 8.75M | 8.24M |
|
|
|||||
| Total Current Liabilities | 10.19M | 13.06M | 11.17M | 8.75M | 8.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.20M | 645.00K | 877.00K | 1.10M | 1.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.39M | 13.70M | 12.05M | 9.85M | 9.56M |
|
|
|||||
| Common Stock & APIC | 532.96M | 509.11M | 480.37M | 476.74M | 472.40M |
| Retained Earnings | -314.64M | -297.01M | -281.01M | -264.01M | -244.93M |
| Treasury Stock & Other | -268.00K | 403.00K | 358.00K | 305.00K | 450.00K |
| Total Common Equity | 218.05M | 212.50M | 199.72M | 213.04M | 227.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 218.05M | 212.50M | 199.72M | 213.04M | 227.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 218.05M | 212.50M | 199.72M | 213.04M | 227.92M |
|
|
|||||